A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus
Crossref DOI link: https://doi.org/10.1007/s40268-016-0134-z
Published Online: 2016-04-20
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pan, Changyu
Gross, Jorge L.
Yang, Wenying
Lv, Xiaofeng
Sun, Li
Hansen, Charlotte Thim
Xu, Hongfei
Wagner, Robert
Funding for this research was provided by:
Novo Nordisk
License valid from 2016-04-20